Skip to main content
. 2023 Nov 30;11(11):e007339. doi: 10.1136/jitc-2023-007339

Table 1.

Assessment of agreement on TMB status between tTMB and bTMB assays

All evaluable pairs (n=1,017) MSAF≥1% (n=806)
tTMB≥10 mut/Mb tTMB<10 mut/Mb tTMB≥10 mut/Mb tTMB<10 mut/MB
bTMB≥10 mut/Mb 96 100 96 100
bTMB<10 mut/Mb 65 756 50 560
PPA, % 60 66

bTMB, blood tumor mutational burden; MSAF, maximum somatic allele frequency; mut/Mb, mutations/megabase; PPA, positive percentage agreement; TMB, tumor mutational burden; tTMB, tissue tumor mutational burden.